DAEWOONG PHARMACEUTICAL CO., LTD.;DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION
发明人:
Sung-Yong OH,Kyung-Hyun MIN
申请号：
US15314282
公开号：
US20170202917A1
申请日:
2015.05.14
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided is a method for preventing or treating skin rash comprising administering to a subject in need thereof epidermal growth factor as an active ingredient. The skin rash includes a skin disorder caused by administering an epidermal growth factor receptor inhibitor, such as erlotinib, as an adverse event.
